Physician profile
Ryan Patrick Murray
NPI 1932333952
$1,077.10
in general payments reported to CMS, 2019-2025
15 companies · $15.92 in 2025
The $15.92 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $233 · 2021: $47.75 · 2022: $342 · 2023: $15.51 · 2024: $18.07 · 2025: $15.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $49.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $49.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $561.61 | 2019-2025 | Wegovy, Saxenda |
| Amgen INC. | $92.57 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $67.20 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $66.49 | 2019-2022 | |
| Lilly USA, LLC | $66.36 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.04 | 2020-2022 | |
| Mannkind Corporation | $43.87 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $36.42 | 2022 | |
| Zealand Pharma US, INC. | $20.09 | 2021 | |
| Dexcom, INC. | $16.46 | 2020 | |
| Abbvie INC. | $15.72 | 2021 | |
| Allergan, INC. | $13.62 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $11.84 | 2022 | |
| Mylan Specialty L.P. | $11.81 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.